[HTML][HTML] Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer
…, N Fukumitsu, T Saito, H Numajiri, KN Murofushi… - Radiotherapy and …, 2019 - Elsevier
Background and purpose We investigated clinical outcomes of proton beam concurrent
chemoradiotherapy (CCRT) for unresectable, locally advanced pancreatic cancer (LAPC) …
chemoradiotherapy (CCRT) for unresectable, locally advanced pancreatic cancer (LAPC) …
[HTML][HTML] Radiation-induced bronchiolitis obliterans organizing pneumonia (BOOP) syndrome in breast cancer patients is associated with age
KN Murofushi, M Oguchi, M Gosho, T Kozuka… - Radiation …, 2015 - Springer
Background Radiation-induced bronchiolitis obliterans organizing pneumonia (BOOP)
syndrome is a rarely observed phenomenon characterized by infiltration of the lungs outside of …
syndrome is a rarely observed phenomenon characterized by infiltration of the lungs outside of …
[HTML][HTML] Incidence and Prognostic Factors of Painful Vertebral Compression Fracture Caused by Spine Stereotactic Body Radiotherapy
…, Y Nakajima, H Ogawa, S Sugita, KN Murofushi - Journal of Clinical …, 2023 - mdpi.com
Most studies of vertebral compression fractures (VCF) caused by stereotactic body radiotherapy
(SBRT) do not discuss the symptoms of this complication. In this paper, we aimed to …
(SBRT) do not discuss the symptoms of this complication. In this paper, we aimed to …
Hypofractionated proton beam therapy for cT1-2N0M0 non-small cell lung cancer patients with interstitial lung disease
…, S Hoshiai, H Numajiri, KN Murofushi… - Anticancer …, 2021 - ar.iiarjournals.org
Background/Aim: To evaluate the outcomes of proton beam therapy (PBT) for early-stage
non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD). Patients and …
non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD). Patients and …
[HTML][HTML] Palliative efficacy of high-dose stereotactic body radiotherapy versus conventional radiotherapy for painful non-spine bone metastases: A propensity score …
K Ito, K Taguchi, Y Nakajima, H Ogawa, KN Murofushi - Cancers, 2022 - mdpi.com
Simple Summary As the superiority of stereotactic body radiotherapy (SBRT) over conventional
external beam radiotherapy (cEBRT) for painful non-spine bone metastases remains …
external beam radiotherapy (cEBRT) for painful non-spine bone metastases remains …
A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma
…, H Numajiri, K Nemoto Murofushi… - Journal of radiation …, 2018 - academic.oup.com
Abstract Development of a curative local treatment for large hepatocellular carcinoma (HCC)
is an important issue. Here, we investigated the dose homogeneity, safety and antitumor …
is an important issue. Here, we investigated the dose homogeneity, safety and antitumor …
Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up …
…, T Kobayashi, K Ohashi, N Doki, KN Murofushi - Annals of …, 2022 - Taylor & Francis
Background and objectives Intensity-modulated radiation therapy (IMRT) helps achieve
good radiation dose conformity and precise dose evaluation. We conducted a single-centre …
good radiation dose conformity and precise dose evaluation. We conducted a single-centre …
[HTML][HTML] A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1)
…, H Baba, N Oya, M Oya, K Nemoto-Murofushi… - Radiotherapy and …, 2016 - Elsevier
Background and purpose Preoperative 5-fluorouracil-based chemoradiotherapy is a standard
treatment for locally advanced lower rectal cancer (LALRC). We performed a phase I study …
treatment for locally advanced lower rectal cancer (LALRC). We performed a phase I study …
Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia
…, T Kobayashi, K Ohashi, N Doki, KN Murofushi - Cancer …, 2023 - Wiley Online Library
This prospective phase I trial aimed to determine the recommended dose of 3‐day total marrow
and lymphoid irradiation (TMLI) for a myeloablative conditioning regimen by increasing …
and lymphoid irradiation (TMLI) for a myeloablative conditioning regimen by increasing …
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10–2 trial)
KN Murofushi, S Itasaka, M Shimokawa… - Journal of Radiation …, 2023 - academic.oup.com
This study assessed the efficacy of chemoradiotherapy for squamous cell carcinoma of the
anal canal (SCCAC). Patients with T1–4N0-3M0 SCCAC received chemoradiotherapy with 5-…
anal canal (SCCAC). Patients with T1–4N0-3M0 SCCAC received chemoradiotherapy with 5-…